Here are relevant reports on : gene-editing-market
-
Viral Vector & Plasmid DNA Manufacturing Market by Type (Viral Vector (Retroviruses, Adenoviruses, AAV, Lentiviruses), Plasmid DNA), Workflow (Upstream, Downstream), Application (Cell & Gene Therapy), Diseases (Cancer), End User - Global Forecast to 2028
The global viral vector manufacturing market, valued at US$4.8 billion in 2022, stood at US$5.5 billion in 2023 and is projected to advance at a resilient CAGR of 18.2% from 2023 to 2028, culminating in a forecasted valuation of US$12.8 billion by the end of the period. The growth of this market is majorly driven by g rising prevalence of target diseases and disorders, the availability of funding for gene therapy development, and effectiveness of viral vectors in gene therapy delivery.
- Published: June 2023
- Price: $ 4950
- TOC Available:
-
Gene Panel Market by Product & Service, Technique (Amplicon, Hybridization), Design (Predesign, Custom), Application (Cancer, Congenital Disease, Pharmacogenetics) & End User (Hospital, Research Center, Pharmaceutical Companies) - Global Forecasts to 2023
The global gene panel market is expected to reach USD 2.95 Billion by 2023, at a CAGR of 19.2%. The growth of this market is mainly driven by the increasing prevalence of chronic diseases, growing company initiatives, and rising adoption of gene panel owing to the benefits they offer. The gene panel market is fragmented, with the presence of several large as well as emerging players. Prominent players in the gene panels market include Illumina, Inc. (US), BGI (China), Agilent Technologies (US), Eurofins Scientific (US), QIAGEN (Germany), GENEWIZ, Inc. (US), Novogene Corporation (China), Personalis (US), Thermo Fisher Scientific (US), F. Hoffmann-La Roche AG (Switzerland), Integrated DNA Technologies (IDT) (US), GATC Biotech AG (GATC Biotech) (Germany), and ArcherDx (US). Players in this market are adopting various organic and inorganic strategies, such as product launches & upgradations, agreements, partnerships, joint ventures, collaborations, and acquisition to widen their product portfolios and expand their presence in the market.
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
Gene Expression Analysis Market by Product (Reagents, Enzymes, Kits, DNA Chips, PCR, NGS, DNA Microarray), Service (RNA Sequencing, Bioinformatics), Application (Drug discovery & Development, Clinical Diagnostics), End User & Region - Global Forecast to 2029
The global gene expression analysis market, valued at US$3.9 billion in 2023, stood at US$4.2 billion in 2024 and is projected to advance at a resilient CAGR of 8.1% from 2024 to 2029, culminating in a forecasted valuation of US$6.2 billion by the end of the period. Growth in this market is primarily driven by the increasing investments by pharmaceutical & biotechnology companies for genome based studies.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Gene Therapy Market by Type (Gene silencing), Vector (Viral (Retroviral, AAV), Non-viral (Oligonucleotide)), Gene Type (Receptors, Cytokine), Therapeutic Area (Oncology, Neurology), Delivery Method (In-Vivo, Ex-Vivo), RoA (IV) - Global Forecast to 2032
The global gene therapy market, valued at US$7.21 billion in 2023, stood at US$8.85 billion in 2024 and is projected to advance at a resilient CAGR of 19.4% from 2025 to 2032, culminating in a forecasted valuation of US$36.55 billion by the end of the period. Market growth is attributed to factors such as the growing demand for curative therapies for genetic disorders, rare diseases, and specific types of cancer, robust clinical trial pipeline for gene therapy and increasing investments in gene therapy research.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Biotechnology Reagents Market by Technology (PCR, Cell Culture, Expression & Transfection, Chromatography, Mass Spectrometry, Electrophoresis, & Flow Cytometry), Applications (Protein Purification, Gene Expression, DNA & RNA Analysis, & Drug Testing) and End-Users - Current Trends, Opportunities and Global Forecasts to 2016
Biotechnology reagents are the substances or compounds used to detect or synthesize another substance in order to provide a test reading. These reagents are used in the field of research, diagnosis, bioscience, and education.
- Published: July 2012
- Price: $ 4950
- TOC Available:
-
Cell & Gene Therapy Manufacturing Services Market Size, Share & Trends by Type (Allogeneic, Autologous, Viral Vector, Non-viral vector), Indication (Oncology, Orthopedic, Ophthalmology), Application (Clinical, Commercial), End User (Pharma, Biotech) - Global Forecast to 2027
The size of global cell & gene therapy manufacturing services market in terms of revenue was estimated to be worth $5.1 billion in 2022 and is poised to reach $11.5 billion by 2027, growing at a CAGR of 17.5% from 2022 to 2027. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.
- Published: January 2023
- Price: $ 4950
- TOC Available:
-
Fiducial Markers Market by Product (Metal Based Markers (Gold, Gold Combination) Polymer Markers), Cancer Type (Prostate, Lung, Breast), Modality (CT, CBCT, MRI, Ultrasound), End User (Hospitals, Outpatient Facilities) & Region - Global Forecast to 2025
The global fiducial markers market growth is primed to transition from $95 million in 2019 to $123 million by 2025, showcasing a strong CAGR of 4.5%. Increasing investments, funds, and grants by public-private organizations for cancer research, technological advancements in the market, and the rising cancer burden globally will fuel market growth over the forecast period.
- Published: February 2020
- Price: $ 4950
- TOC Available:
-
Adipose Derived Stem Cell Market by Type (Autologous, Allogeneic), Product (Cell Line. Culture Media), Disease (CVS, CNS, MSK, Obesity, Cancer), End User (Hospitals, Tissue Banks, Academia), Application (Therapeutics, Research) - Global Forecasts to 2019
Emerging markets including China, India, South Korea, and Brazil have become attractive destinations for companies engaged in the development and manufacturing of adipose derived stem cell products. A number of factors such as growing preference for use of adipose derived stem cells in therapeutics and emerging markets offering low regulatory barriers for conducting clinical studies are offering new growth opportunities for players active in the global adipose derived stem cell market
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Automotive Seating Systems Market-Trends and forecast
This report is a professional and in-depth study on current state of the Automotive Seating Systems market. The report provides key statistics on the market status and is a valuable source of guidance and direction for companies and individuals interested in this industry. The report also covers competitive landscape, recent developments and strategies for major players in this market.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
AR and VR Display Market by Device Type (AR HMDs, VR HMDs, AR HUDs, VR Projectors), Technology, Display Technology (LCD, OLED, Micro-LED), Application (Consumer, Commercial, Enterprise, Healthcare, Aerospace & Defense) & Region - Global Forecast to 2028
The global AR and VR display market is expected to grow from USD 1.8 billion in 2023 to USD 8.2 billion by 2028, at a compound annual growth rate (CAGR) of 35.6% during the forecast period.The Key Players Samsung Electronics (South Korea), Sony (Japan), LG Display (South Korea), eMagin Corporation (US), Kopin Corporation (US), AU Optronics (Taiwan), Japan Display (Japan), Barco (Belgium), BOE Technology (China), and Syndiant (US)
- Published: February 2023
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
